Description
Ligandrol, or LGD-4033, is a member of the selective androgen receptor modulator (SARM) family, designed for research purposes to explore its potential therapeutic applications in addressing muscle-wasting conditions and osteoporosis.
One of the key features of Ligandrol is its selective binding to androgen receptors in the body, primarily in muscle and bone tissues. This targeted interaction allows it to activate specific pathways that promote muscle protein synthesis and enhance muscle growth, leading to an increase in lean muscle mass and improved strength.